Recruiting Atopic Dermatitis Studies in Tulsa
Artificial Intelligence to Measure Adherence to Oral Medication
The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis....
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
The purpose of this trial is to test whether treatment with tralokinumab (administered subcutaneous injections \[SC\]) in combination with topical corticosteroids (TCS) is safe and effective to treat ...
About Atopic Dermatitis Clinical Trials in Tulsa
Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.
There are currently 2 atopic dermatitis clinical trials recruiting participants in Tulsa, OK. These studies are seeking a combined 395 participants. Research is being sponsored by Northwell Health, LEO Pharma. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atopic Dermatitis Clinical Trials in Tulsa — FAQ
Are there atopic dermatitis clinical trials in Tulsa?
Yes, there are 2 atopic dermatitis clinical trials currently recruiting in Tulsa, OK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Tulsa?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tulsa research site will contact you about next steps.
Are clinical trials in Tulsa free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tulsa studies also compensate for your time and travel.
What atopic dermatitis treatments are being tested?
The 2 active trials in Tulsa are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.
Data updated March 2, 2026 from ClinicalTrials.gov